Global $4.7 Billion Cell Viability Assays Market Trajectory & Analytics, 2012-2019 & 2020-2027 - ResearchAndMarkets.com

·5 min read

The "Cell Viability Assays - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Cell Viability Assays Market to Reach $4.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Cell Viability Assays estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at a CAGR of 7% over the period 2020-2027.

Consumables, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U. S. Market is Estimated at $864.6 Million, While China is Forecast to Grow at 6.5% CAGR

The Cell Viability Assays market in the U. S. is estimated at US$864.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$821.8 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

The 235-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • Abcam PLC

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories, Inc.

  • BioTek Instruments, Inc.

  • Biotium, Inc.

  • Creative Bioarray

  • Danaher Corporation

  • GE Healthcare

  • Merck KgaA

  • PerkinElmer, Inc.

  • Promega Corporation

  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares

  • Cell Viability Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • Cell Viability Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027

  • Cell Viability Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019

  • Cell Viability Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027

  • Consumables (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027

  • Consumables (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019

  • Consumables (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

  • Instruments (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027

  • Instruments (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019

  • Instruments (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

  • Basic Research (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027

  • Basic Research (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019

  • Basic Research (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

  • Stem Cell Research (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027

  • Stem Cell Research (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019

  • Stem Cell Research (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027

  • Drug Discovery & Development (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027

  • Drug Discovery & Development (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019

  • Drug Discovery & Development (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027

  • Clinical & Diagnostic Applications (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027

  • Clinical & Diagnostic Applications (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019

  • Clinical & Diagnostic Applications (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027

  • Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027

  • Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019

  • Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027

  • Academic & Research Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027

  • Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019

  • Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027

  • Pharmaceutical & Biotechnology Companies (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027

  • Pharmaceutical & Biotechnology Companies (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019

  • Pharmaceutical & Biotechnology Companies (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

  • Hospital & Diagnostic Laboratories (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027

  • Hospital & Diagnostic Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019

  • Hospital & Diagnostic Laboratories (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027

  • Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027

  • Other End-Uses (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019

  • Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/d5tf2a

View source version on businesswire.com: https://www.businesswire.com/news/home/20201023005260/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900